1972
DOI: 10.1111/j.1600-0609.1972.tb00936.x
|View full text |Cite
|
Sign up to set email alerts
|

Killing and Characterizing Action of Colchicine in vitro on Lymphocytes of Chronic Lymphocytic Leukaemia

Abstract: Circulating lymphocytes in chronic lymphocytic leukaemia (CLL) that die in vitro in 1 day of culture with 10‐7 M‐colchicine (0.04 μg per ml) have been classed as abnormal cells. Most of the increase in peripheral count in 30 patients so far tested (treated or untreated) is due to cells of this type. A colchicine concentration 100, 000 times greater (10‐2 M) kills peripheral populations from healthy individuals in one day. Use of nuclear pyknosis as the index of death has been validated by metabolic and ultrast… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1974
1974
1994
1994

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 27 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…A variety of cell studies served to aid in the diagnosis of PLL and/or contribute to its designation as a B-cell malignancy (which was the case for all 6 patients). These studies included morphological identification of prolymphocytes in blood films (results available for cases I1 (19%), I11 ( 3 5 % ) , IV (27%) and V (76%)), tests for the presence of cell surface antigens using a panel of monoclonal antibodies, including PLL marker FMC7 (23), and a culture test for enumerating lymphocytes ultrasensitive to the cytocidal action of colchicine (at 10-' mol/l), this latter property having been established as a marker for pathological cells in B-cell CLL (24,25). Patients I1 and I11 showed the additional presence of atypical, unidentifiable mononuclear cells.…”
Section: Patientsmentioning
confidence: 99%
See 1 more Smart Citation
“…A variety of cell studies served to aid in the diagnosis of PLL and/or contribute to its designation as a B-cell malignancy (which was the case for all 6 patients). These studies included morphological identification of prolymphocytes in blood films (results available for cases I1 (19%), I11 ( 3 5 % ) , IV (27%) and V (76%)), tests for the presence of cell surface antigens using a panel of monoclonal antibodies, including PLL marker FMC7 (23), and a culture test for enumerating lymphocytes ultrasensitive to the cytocidal action of colchicine (at 10-' mol/l), this latter property having been established as a marker for pathological cells in B-cell CLL (24,25). Patients I1 and I11 showed the additional presence of atypical, unidentifiable mononuclear cells.…”
Section: Patientsmentioning
confidence: 99%
“…Cell survival was again calculated from c(1-p), where "c" corrects for any disappearance of cells (found in this study by haemocytometer counting) and represents the fraction remaining intact (dead or alive) and "p" is the "slide death", namely the fraction of the intact cells (500 examined) in wet-fixed (Susa) smears stained with Mayer's haemalum (27) seen to exhibit nuclear pyknosis, a validated index of lymphocyte death (24).…”
Section: Mathematical Modelsmentioning
confidence: 99%